Petri dish and a pipette on a blue background in a scientific genetic laboratory

Be a REBEL with Your Cell Media Analytics

In this GEN webinar, sponsored by 908 Devices, our presenters will walk us through the fundamentals surrounding new cutting-edge technology that can perform rapid analysis straight from the lab bench.
T cell fighting Cancer

CAR-T Therapy: Working with a Manufacturing Partner

In this roundtable hear from four distinguished experts as they critically weigh the benefits of working with a manufacturing partner. This roundtable, sponsored by Catalent, is a must-see for early and late-stage cell therapy innovator companies who are considering a manufacturing partnership.
Embryonic stem cells

Right First Time: Successfully Progressing Biotherapeutics from Discovery to the Clinic

A large proportion of initially promising biotherapeutic candidates never make it to commercialization. It is critical to evaluate potential liabilities as early as possible during molecule design and utilize lead selection phases to increase the chances of identifying a successful candidate significantly. It is also essential that the best approaches and tools are selected to maximize success when moving the selected candidate through development. In this GEN webinar, we will introduce strategies and tools to increase the chance of success through both of these stages.
Walter Isaacson in the lab

The Story of CRISPR: Walter Isaacson

In the March episode of GEN Live, we are thrilled to welcome Walter Isaacson, who gives one of his first in-depth interviews on his new book The Code Breaker, published this month. We’ll talk to Walter about his impressions of Doudna and other key members of the CRISPR community, the impact of COVID-19, the role of innovation in science, and other adventures in gene editing and storytelling.
Too many investigators spend more time prepping their experimental results for analysis than they do performing the critical analysis itself—studies suggest data-wrangling consumes as much as 60% of the time spent working with data. Moreover, research data used for various analyses are frequently shelved when the data crunching is complete and is then consigned to a virtual wasteland of hard drives and cloud storage. Yet, this metadata is an invaluable and often underutilized resource that can save significant time when applied to subsequent experiments, making each new experiment more efficient. Nowhere is this data management challenge more acute than in the Omics fields. Genomic, transcriptomic, and proteomic experiments generate huge amounts of data—and oftentimes, researchers are unaware of the tools available to aggregate, connect, and harmonize that data so it can easily be put to good use. And more importantly, to reuse. In this GEN Webinar, we will hear about the challenges facing research teams as they work to curate large omics data sets in preparation for analysis. We will then explore modern strategies and technical approaches that can dramatically simplify and improve the process.

Solving Metadata Management from Sample Provenance through Omics

In this GEN Webinar, sponsored by Snthesis, we will hear about the challenges facing research teams as they work to curate large omics data sets in preparation for analysis. We will then explore modern strategies and technical approaches that can dramatically simplify and improve the process.

Redesigning CHO: The New Frontier in Bioprocessing?

In this GEN webinar, sponsored by Horizon, we will hear about the gene-editing tools and options available at Horizon Discovery to customize the CHO expression host for both research and commercial use to suit specific needs during discovery, development, and protein production.
Blood test, DNA

Creating the Future of Cell and Gene Therapies

In this GEN webinar, sponsored by PerkinElmer, our distinguished presenters will provide perspectives on how the gene therapy field ought to evolve. From the early vector systems, which often represented replicating viruses, to the recent sophisticated engineering of targeted virus driven cell and gene therapies that have demonstrated clinical benefits and gained FDA approval for multiple diseases.
CRISPR-Cas9 gene editing complex, illustration

Advancing Direct Enzyme Delivery for Therapeutic Genome Editing In Vivo

In this GEN webinar, sponsored by Aldevron and Synthego, we will hear how the Wilson lab works to advance this approach by performing molecular engineering, giving CRISPR enzymes the properties necessary for safe, efficient, and accessible delivery in a clinical setting. These efforts will enable in vivo delivery of CRISPR enzymes, including hard-to-deliver tools such as base editors and prime editors.
Coronavirus COVID-19 and blood cells in bloodstream

Accelerating Vaccine Development Using a Next-Gen Microfluidic CE Platform

In this GEN webinar, sponsored by PerkinElmer, we will find out about an exciting protein characterization system that addresses many of the challenges researchers face during vaccine development projects. We will also learn about key applications of microfluidic chip-capillary electrophoresis in vaccine process development.

Accelerating Vaccine Development and Large-Scale Manufacturing with Advanced Purification Tools

Join this GEN webinar, sponsored by Thermo Fisher Scientific, and learn more on novel purification solutions that can help accelerate early vaccine candidate screening and improve the downstream process of different vaccine modalities such as mRNA, recombinant proteins, and Virus-Like Particles (VLPs). In addition, a new scavenging method for the removal of Baculovirus process impurities will be presented.
Scroll Up